logo

On demand webcast

Hypertension
How low should you go?
Whose guidelines are tailored better to reality:
USA or Europe?

Barcelona · October 1st 19:00 h · CEST

Video
speakers

Program

Barcelona · October 1st

HYPERTENSION, HOW LOW SHOULD YOU GO? WHOSE GUIDELINES ARE TAILORED BETTER TO REALITY: USA OR EUROPE?

DISCUSSION ON THE LATEST HYPERTENSION GUIDELINES

19:00 – 19:10

Highlights from the latest American and European hypertension guidelines

19:10 – 19:20

Guidelines versus clinical practice: The pursuit of perfect blood pressure target

19:20 – 19:30

Improving adherence and overcoming clinical inertia in hypertension

19:30 – 19:45

Closing: questions from the audience

Prof. Claudio Borghi (Italy) and Prof. Antonio Coca (Spain)

Speakers

team image

Prof. Claudio Borghi

Italy

team image

Prof. Antonio Coca

Spain

project image

Prof. Claudio Borghi

Claudio Borghi is Professor of Medicine at the University of Bologna.

He received his medical degree at the University of Bologna and completed his clinical fellowship at the Department of Cardiology and then at the Department of Clinical Pharmacology of the University of Bologna.

His research experience is mainly focused on cardiovascular medicine with a focus on the clinical epidemiology of CV risk factors and the pharmacological and therapeutic aspects of hypertension, dyslipidemia, coronary artery disease and congestive heart failure.

He is currently Chief of the Department of Medicine of the Policlinico S.Orsola-Malpighi-Bologna and Head of the Hypertension Unit and the ESH Excellence Center for hypertension.

He is the Past-President of the Italian Society of Hypertension and the Foundation for Hypertension Research of the same Society.

Dr.Borghi was the head of the post-graduate Medical School on Respiratory diseases.

He is currently the head of the post-graduate medical school on Emergency Medicine.

Dr.Borghi is the scientific coordinator of the PhD program on Health and Technology of the University of Bologna.

He is member of the Executive Council of the International Society of Hypertension and the European Society of Hypertension.

Dr.Borghi is member of the Nucleus of the ESC Working Group on Cardiovascular Therapeutics.

Prof.Borghi is member of the Editorial Board of several scientific journals (PLOS ONE, J Hypertension, International J of Hypertension, BMC Medicine, Medicine) and is member of the board of reviewers for the European Heart Journal, New England Journal of Medicine, Lancet, Hypertension, Circulation, British Journal of Clinical Pharmacology, American Journal of Hypertension, American Journal of Medicine, Atherosclerosis, Journal of Endocrinology, International Journal of Cardiology, Clinical Pharmacokinetics, Clinical Pharmacology and Therapeutics.

He has a broad experience in the organization and conduction of all phases clinical trial research and has served as principal Investigator of many large morbidity and mortality trials, interventional trials and epidemiological surveys in hypertension, hyperuricemia, coronary artery disease and atherosclerotic disease.

Dr.Borghi is member of the Working Group of Clinical Pharmacology and Therapeutic and member of the writing committee for the guidelines about the management of cardiovascular diseases during pregnancy of the European Society of Cardiology.

Dr.Borghi is actually member of the board of reviewers for the ESC-ESH Guidelines for the treatment of Arterial Hypertension.

Dr.Borghi is ordinary and honorary member of many international scientific societies (ISH, ESH, ESC, ASH, AHA, Venezuelan Society of Cardiology, Mexican Society of Cardiology).

He is Scientific Fellow of the American Heart Association and European Society of Cardiology.

Prof.Borghi is author and co-author of 453 peer-review scientific publications and many other scientific contributions (manuscripts, book chapters, monographies, e-books) in the field of hypertension, CV risk factors and drug treatment of cardiovascular diseases.

BACK
project image

Prof. Antonio Coca

Antonio Coca is Emeritus Professor of Internal Medicine, School of Medicine, University of Barcelona, Spain. He is Past-Chief of the Hypertension and Vascular Risk Unit of the Department of Internal Medicine at the Hospital Clinic, Barcelona, Spain.

He obtained his MD and PhD degree from the University of Barcelona, Spain. Professor Coca is past-President of the Spanish Society of Hypertension, honorary member of the Latin American Society of Hypertension, the Central American Society of Hypertension, the Argentinian Society of Hypertension, the Venezuelan Society of Hypertension, the Peruvian Society of Cardiology and the Portuguese Society of Hypertension.

Fellow of the Royal College of Physicians of London, and Fellow of the European Society of Cardiology. In 2007 he was elected member of the Scientific Council of the European Society of Hypertension, where he is responsible for relationships with Latin America serving currently as “Executive-Officer”.

He is the past-Chair of the ESH WG on the Brain & Hypertension, past-Chair of the ESC Council on Hypertension, and past-member of the Committee for Practice Guidelines of the European Society of Cardiology.

Professor Coca is Editor or co-Editor of 58 books on various topics within the field of hypertension.

He has published more than 500 papers in international journals and has presented more than 450 invited lectures at international and national meetings and universities.

He has been member of the steering committee, as well as the Spanish coordinator, of several large-scale international trials in hypertension.

BACK
REGISTER FOR ON DEMAND WEBCAST
HYPERTENSION, HOW LOW SHOULD YOU GO? WHOSE GUIDELINES ARE TAILORED BETTER TO REALITY: USA OR EUROPE? DISCUSSION ON THE LATEST HYPERTENSION GUIDELINES
* indicates required

Privacy notice
By sending this form, as well as by expressly accepting the legal terms and conditions and when applicable, if you have checked the box accepting the reception of commercial information through Newsletters, you expressly consent that Sanofi-Aventis S.A (“Sanofi”), acting as the controller of processing your personal data, will process and manage the personal data that you have written in such registration form, with the purpose of interact and access to the contents of the Website and also with the purpose of manage the sending of customized commercial electronic communications, such as medical-scientific information, news and initiatives related to your clinical field or other fields that could be interesting for you and also to manage the sending of products and corporate news related to Sanofi, including the provision of services of online training which are accessible though the website of Sanofi. Such consent is the legal basis to process your personal data.
Likewise, we inform you that your personal data could be communicated, in order to fulfil the abovementioned purposes, to other entities which belong to the Sanofi Group and to third parties that provide Sanofi with support services and that process information as data processors on behalf of Sanofi (such as providers of technologic services).
We inform you that you can exercise the right of access, cancel, rectification, data portability, erasure, restriction and object of processing with regards to your personal data and you can withdraw your initial consent at any time according with the applicable personal data protection regulation (Organic Law 115/1999, of 13 December, Royal Decree 1720/2007, of 21 December which develops such Organic Law and also according with the General Data Protection Regulation (EU) 2016/679, of the European Parliament and of the Council of 27 April 2016). In this case, you should send a written communication to Sanofi-aventis, S.A., C/ Josep Pla nº 2, planta 4ª, Edificio Torre Diagonal Mar, 08019 Barcelona or send an email to the following address:esprotecciondedatos@sanofi.com, in which you will have to attach, in both cases, a copy of you ID, passport or any other valid document that identifies you and you should refer to the specific website according to the provisions of the applicable data protection regulation. Likewise, if you consider that we have not resolve your petition related to the exercise of your rights in a proper way, you could submit a complaint before the Spanish Data Protection Agency in the following address: https://sedeagpd.gob.es.
Sanofi will keep your personal data during the period foreseen in the applicable regulation. Once the period in which any liabilities can be claimed has terminated, your data will be destroyed. The data that you have provided Sanofi will be kept as long as you maintain the current registration and as long as you do not communicate us your intention to withdraw your consent.
In case of doubt or in the event that you want to ask us anything related to how we process your personal data you can contact us in the following address: esprotecciondedatos@sanofi.com. If you want more information with regards our Privacy Policy, you can access to the following link: Sanofi’s Data Privacy Policy.

Back